Summary & Overview
HCPCS J2275: Morphine Sulfate Injection, Preservative-Free, per 10 mg
HCPCS Level II code J2275 identifies a preservative-free morphine sulfate sterile solution for injection, billed per 10 mg unit. This medication code matters nationally because morphine remains a foundational opioid analgesic used across acute care settings — from emergency departments and inpatient wards to ambulatory procedure suites — for moderate to severe pain management and procedural analgesia. Accurate coding affects drug utilization tracking, billing accuracy, and opioid stewardship efforts.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of what the code represents, typical sites of service, and the clinical context for use. The publication also provides benchmarking and reimbursement considerations, common billing practices, and any relevant policy and coverage themes that influence claims handling for parenteral morphine.
This summary equips revenue cycle leaders, clinical pharmacists, and coding professionals with the context needed to align documentation and billing for injectable morphine. It highlights where variability commonly occurs, what to monitor for compliance and utilization management, and the implications of unit-based billing on reporting and cost accounting. Data not available in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code J2275 denotes an injection of morphine sulfate (preservative-free sterile solution), per 10 mg. This code represents a parenteral opioid analgesic preparation supplied for administration by healthcare professionals.
Service type: injectable medication administration (opioid analgesic)
Typical site of service: inpatient hospital units, outpatient hospital clinics, ambulatory surgery centers, emergency departments, and other settings where parenteral analgesia is administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient infusion center, emergency department, or inpatient medical unit for treatment of moderate to severe acute pain or chronic cancer-related pain requiring parenteral opioid therapy. The clinician evaluates pain severity, prior opioid exposure, allergies, and contraindications to morphine. A preservative-free sterile morphine sulfate solution is prepared in a pharmacy or point-of-care medication room and administered by a registered nurse via intravenous push, slow IV infusion, or subcutaneous injection depending on clinical need and patient venous access. Vital signs, respiratory status, and level of consciousness are monitored before, during, and after administration. Documentation includes medication name J2275 (morphine sulfate preservative-free), dose in mg, route of administration, time, indication, patient response, and any adjunctive medications (antiemetics, naloxone if needed). Typical scenarios include acute post-operative pain, vaso-occlusive crisis in sickle cell disease, severe cancer pain requiring parenteral opioid, or severe traumatic pain when oral intake is not feasible.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 | Distinct procedural service | When a separate and distinct non-overlapping service is provided the same day as another service |